Sarcoma News

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

“There are many exciting studies in progress to look forward to” at future Connective Tissue Oncology Society meetings, according to Candace Haddox, MD.

Candace Haddox, MD, explored advances in genetic sequencing for sarcomas, which was a major theme of the Connective Tissue Oncology Society Annual Meeting, in this video interview with Healio.

In this video, Candace Haddox, MD, discussed a few presentations from the Connective Tissue Oncology Society Annual Meeting that focused on how better understanding of sarcoma biology could lead to clinical advancement.

In this video, Chandrajit Raut, MD, MS, discussed results from the first study using a registry trying to “raise the quality of surgery” for retroperitoneal sarcomas, which was presented at the Connective Tissue Oncology Society Annual Meeting.

Chandrajit Raut, MD, MS, talked about a video session at the Connective Tissue Oncology Society Annual Meeting on approaching oncologic surgery for sarcoma specialists.

In a video interview with Healio, Chandrajit Raut, MD, MS, discussed highlights from “one of the best” Connective Tissue Oncology Society meetings he has attended.

Sandra D’Angelo, MD, discussed a clinical trial on trabectedin in combination with low-dose irinotecan in Ewing sarcoma presented at the Connective Tissue Oncology Society Annual Meeting.